The big news in David Systrom’s “Neurovascular Dysregulation Underlies Exercise Intolerance in ME/CFS” talk at the CDC yesterday was that the $8 million mitochondrial drug trial had, unfortunately, failed. The ME/CFS Mitochondrial Drug Trial Fails Mitochondrial disease is usually associated with genetic abnormalities, but Systrom emphasized that most mitochondrial diseases … Continue reading Systrom at the CDC: The ME/CFS Mitochondrial Drug Trial Fails Plus More